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The Tla locus belongs to a  family of some 36 class I genes (1,  2) that occupy 
the extended  major histocompatibility complex  (H-2:Qa:Tla)  region  of mouse 
chromosome  17.  The  relatedness of class  I  genes is indicated and defined by 
crosshybridization of H-2  DNA probes  with members of this family, and by a 
characteristic product structure consisting of a  heavy (H) ~ chain of 40-50,000 
mol  wt,  associated  with  a  /3-2 microglobulin  subunit,  coded  elsewhere.  The 
sharpest biological distinction between members of this family rests in differential 
expression,  since  H-2  products  are  probably  expressed  by  all  somatic  cells, 
whereas the expression of Qa:Tla  genes is restricted to only some cell lineages. 
Polymorphism ranges from extreme, in the case of H-2K (3), to little or none in 
tbe  case  of Qa-2  (4),  otherwise  there  is  little  to  categorically distinguish  the 
products of different class I genes from one another. 
The  structure  of the thymus leukemia antigen (TL) is of particular interest 
for  several  reasons  (5),  notably  in  the  aberrant  expression  of TL  by  T  cell 
leukemias of TL-  mouse  strains  that  never  normally express  TL,  and  in  the 
phenomenon of antigenic modulation (loss of the TL phenotype on exposure of 
TL  +  cells  to  TL  antibody),  which  completely  deprives  TL  of any  function 
whatever as a  histocompatibility antigen, in striking contrast to its fellow class I 
H-2 antigens. Here we give evidence that TL, the Tla product, is distinguished 
by certain features of its H  chain, and by the occurrence of additional products 
of higher molecular weight. 
Materials and Methods 
Mice.  A/J,  A.TH,  BALB/cJ,  B10.M,  A.CA,  BDP/J,  P/J,  129  and  C57L/J  were 
purchased from The Jackson Laboratory (Bar Harbor,  ME).  BALB/cBoy and B6-Tla  a 
congenic mice were from colonies kept at Memorial Sloan-Kettering Cancer Center. 
Cells.  Thymocytes for radiolabeling were obtained from male mice aged 8-12  wk. 
The B6  leukemia ERLD was passed in B6  females, and the cells were recovered from 
spleen. The source of ASL1  (A strain) leukemia cells was the ASLI.1  line adapted to 
culture  by  Dr.  R.  Hyman  (Salk  Institute,  La Jolla,  CA),  kindly provided  by  Dr.  E." 
Rothenberg (California Institute of Technology, Pasadena, CA). 
This work was supported in part, by grants from the National Institutes of Health, Bethesda, MD, 
and from the American Cancer Society. 
i Abbreviations used in this paper:  2D IEF, two-dimensional  isoelectric focusing; H, heavy chain; 
mAb, monoclonal antibody; NP-40, nonidet P-40; PAS, protein A-Sepharose; PBS, phosphate- 
buffered saline; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide  gel electrophoresis; TL, thymus 
leukemia antigen. 
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Antisera.  The standard TL antiserum used was (B6 × A-Tlab)Fl anti-A strain leukemia 
ASL1. 
Radioiodination, Cell Lysis, and lmmunoprecipitation.  Essentially according to Vitetta et 
al.  (6),  5  x  10 7  thymocytes or  leukemia cells  were  labeled  with  2-20  mCi  of Na125I 
(Amersham Corp., Arlington Heights, IL) by lactoperoxidase catalysis.  Cells to be labeled 
were suspended in  1 ml of phosphate-buffered saline (PBS) to which we added 200 #1 of 
PBS containing 200  t~g of lactoperoxidase (Sigma Chemical Co.,  St.  Louis,  MO).  The 
reaction was initiated by addition of 10 ul of a 0.03% H2Oz solution. After 5 and 10 min, 
an additional  10 t~l of H202 solution were added.  20 rain after the first H~O2 addition, 
labeling was terminated by washing the cells twice with 50 ml of ice-cold PBS.  The cells 
were lysed in 2 ml of PBS containing 0.5% Nonidet P-40 (NP-40)and I mM phenylmeth- 
ylsulfonyl fluoride. The lysates were cleared in an Eppendorf microcentrifuge and used 
immediately for immunoprecipitation. 
Immunoprecipitation was effected by antibodies bound to Protein  A-Sepharose 4  B 
(PAS) beads (Pharmacia  Fine Chemicals,  Piscataway, NJ).  PAS beads (1.5  g) were first 
swollen with  15 ml of PBS containing 0.01% sodium azide and stored at 4 ° C. Generally, 
10 #1 of serum or ascites fluid was added to 100 ~1 of bead suspension, and the mixture 
was shaken for 15-30 min at 23 °C. The antibody-bead complex was then washed three 
times with  15 ml of ice-cold PBS containing 0.5%  NP-40. 200 #1 of lysate (5  X 106 cell- 
equivalents) was then added to the washed bead pellet, and the mixture was again shaken 
for 30 min at 23°C. Afterwards, the bound immune complexes were washed four times 
with PBS with 0.5% NP-40, and once with a low-salt detergent buffer (2 mM Tris, 0.5% 
NP-40, pH 7.4).  After this last wash, the PAS beads were centrifuged through a cushion 
of low-salt buffer containing 20% sucrose. 
Electrophoresis.  Sodium  dodecyl  sulfate-polyacrylamide  gel  electrophoresis  (SDS- 
PAGE) was performed according to Laemmli (7) using 12% acrylamide. Molecular weight 
standards (Pharmacia Fine Chemicals) included phosphorylase b (94,000), bovine serum 
albumin  (67,000),  ova|bumin  (43,000),  actin  (42,000),  carbonic  anbydrase  (30,000), 
soybean trypsin inhibitor (20,100),  a-lactalbumin (14,400),  and cytochrome c  (13,400) 
(Sigma Chemical  Co.).  Two-dimensional isoelectric focusing (2D  IEF)-SDS-PAGE was 
performed according  to  O'Farrell  (8).  All  SDS-polyacrylamide gels  were  dried  under 
vacuum and exposed to Kodak X-omat AR film at -70°C using Dupont Cronex intensi- 
fying screen. 
Peptide Mapping.  2D peptide mapping of 125I-labeled TL (eluate of the specific SDS- 
PAGE band) was performed according to Elder et al.  (9).  Chymotrypsin was used at a 
concentration of 50 t~g/ml in ammonium bicarbonate buffer, pH 8.3. 
Results 
SDS-PAGE  Characteristics  of TL 
Thymocytes: doublet H chains.  Figs. 1 and 2 show SDS-PAGE of TL precipitated 
from thymocytes with  various anti-TL  monocional antibodies  (mAb) (10),  and 
with conventional TL antiserum.  TL appears as two closely migrating bands of 
similar intensity  in  the  H  chain  region  (45-50,000  tool  wt).  This doublet  pat- 
tern,  observed  originally  with  B6-Tla"  thymocytes  (11),  was  invariably  seen 
also with  thymocytes of all  TL + mouse strains  tested  (A,  B6-Tla",  C58,  SjL/j, 
A.TH  [Tla"];  BALB/cBoy,  BALB/cJ  [Tla¢];  B10.M,  A.CA  [Tlaa];  BDP/J,  P/J 
[Tlae];  C57L/J,  129  [Tlaf]).  H-2 precipitated  with anti-H-2 sera from the  same 
materials  in  no  case  showed  a  doublet  H  chain  pattern.  TL  is  less  readily 
precipitated from Tla c and Tla f thymocytes than from thymocytes of other  Tla 
types,  but  nevertheless,  the  characteristic  H  chain  doublet  was apparent.  Fine 
differences  in  SDS-PAGE  migration,  which  distinguish  some  but  not  all  Tla 
genotypes from one another, affect the two bands of the doublet equally. CHORNEY  ET  AL.  783 
FIGURE  I.  SDS-PAGE of TL fi'om Tla  ~ (BDP/J) thymocytes, showing the doublet H chain 
(47,000 and 49,000 mol wt) and TL products of higher molecular weight (52,000 and 53,000). 
The weak representation of the higher-molecular weight TL with mAb (TL.m4,  5, 6, and 8), 
as compared with antiserum (anti-TL),  is due to the underexposure needed to distinguish the 
two  bands of  H  chain doublet clearly,  mAb TL.m9  is a  negative  control, because  Tla  e 
thymocytes do not express TL.m9 antigen (10). The uppermost band with anti-TL is retroviral 
gp70 precipitated  by anti-gp70 present in this antiserum. 
FIGURE  2.  SDS-PAGE of" TL ti'om Tla  ° (B10.M) thymocytes, showing the doublet H chain 
and a TL product of higher molecular weight. The underexposure needed to show the H 
chain doublet distinctly with mAb is insufficient for showing the high-molecular weight band 
that is strongly seen in this figure only with TL antiserum (anti-TL).  mAb TL.m9 and TL.m8 
are negative controls (10). (See legend to Fig. 1  .) 
TL  of higher  molecular  weight.  A  major feature of TL  from  Tla e  thymocytes 
(strains BDP/J  [Fig.  1] and P/J  [not shown]), which is not seen with thymocytes 
of the prototype TL + strain A  (Tlaa),  is the presence of additional Tla e bands of 784  STRUCTURAL CHARACTERISTICS OF  Tla  PRODUCTS 
FIGURE 3.  2D IEF-SDS-PAGE of TL from thymocytes  (thy) and leukemia  cells (ASLI and 
ERLD).  First  dimension,  pH  5-8  gradient;  second dimension,  12%  polyacrylamide.  The 
doublet H chain conformation typical of thymocytes (upper three panels) is lacking in leukemia 
cells (lower  two panels).  The two doublet components have  the same  charge.  Products of 
higher molecular  weight,  illustrated  here with Tla  ~ and Tla  d thymocytes,  are not seen with 
Tla  a thymocytes.  The second component (53,000 mol wt) seen with ERLD leukemia cells is 
an additional  product, not a conventional  H chain.  Retroviral  gp70, which is recognized by 
anti-gp70 in the TL antiserum  used, is not shown because the figures were cut to display only 
the regions of interest. 
higher mol wt (~52,000  and 53,000).  In the case of Tla  d (strains  B10.M  [Fig.  2] 
and  A.CA  [not  shown]),  there  was  a  single  band  of higher  mol  wt  (~53,000). 
Neither  the  53,000  mol  wt  nor  any  other  specific  band  was  obtained  from 
controls  in  which  B10.M  spleen  cells  were  substituted  for  B10.M  thymocytes. 
No  corresponding  additional  bands  were  seen  with  H-2  precipitates  from  the 
same material. 
Leukemia cells.  Although  TL  from  thymocytes  of  all  TL +  mouse  strains, 
regardless  of  Tla  genotype,  yielded  H  chains  showing  the  characteristic  and 
equally  intense  doublet  bands  (see  above),  TL  from  leukemia  ASL1  (a  sponta- 
neous A  strain  leukemia in culture),  and from the B6 radiation  leukemia  ERLD, 
gave only a  single  H  chain  band.  ERLD  ceils  yielded  an additional  product  of 
~53,000  mol wt, evidently corresponding to the higher molecular weight prod- 
ucts already noted. ASL1 cells, like A  strain thymocytes, gave no such additional 
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FIGURE 4.  2D chymotryptic peptide maps of the two H  chain bands  from Tla  ~ thymocytes 
separated individually from an SDS-PAGE gel, showing no significant difference. The doublet 
bands from Tla  a thymocytes and from Tla  d thymocytes gave similar results. 
219 IEF-SDS-PAGE  Characteristics  of TL 
Thymocytes.  Fig. 3 shows 2D IEF-SDS-PAGE patterns of TL from thymocytes, 
according  to  Tla  genotype.  In  no instance  were the two components of the H 
chain doublet distinguishable  by charge.  The patterns for H  chains of Tla a and 
Tla e thymocytes, which differ serologically only for TL.m9 and TL.m7 antigens 
(10), were not distinguishable, but differed from the pattern typical of Tla c, Tla d, 
and  Tla f  in  being more  basic and  showing more  microheterogeneity;  thus  the 
patterns of TL from normal thymocytes fall into two main groups. 
The higher-molecular  weight TL products that we find associated with Tla c-f 
but not  Tla a are,  in each case, distinguishable  by charge from the respective H 
chain doublet, as is illustrated in Fig. 3 for Tla e and Tla d. 
Leukemia  cells.  In 2D IEF-SDS-PAGE, the single H  chain band (45,000 mol 
wt) from ASL1 leukemia cells of the A strain (Tta a) differed from H chains of A 
strain thymocytes (although the peptide maps were the same, see below), but was 
somewhat similar to the 50,000 mol wt H  chain  of ERLD leukemia cells of the 
B6 strain  (Tla b) (Fig.  3). 
2D  Chymotryptic  Peptide  Mapping  of TL 
Thymocytes.  The two bands of the H  chain doublet were separately removed 
from SDS-PAGE gels and examined by 2D-chymotryptic peptide mapping.  Maps 
of the two H chain bands from Tla  ~ thymocytes (Fig. 4) were not distinguishable, 
nor could the  maps of the two  Tla ~ H  chain  bands  be distinguished  from one 
another (not shown). 
Comparison  of H  chain  maps of TL from  Tla a and  Tla ~ thymocytes showed 
little difference, in keeping with the close similarity of serological phenotype and 
charge.  H  chain  maps  for  Tla c and  Tla a  thymocytes were  very similar  to one 
another  and  clearly  different  from  the  Tla ~ and  Tla*  pattern,  although  there 
were shared  features.  These  data,  illustrated  in  Fig.  5,  are in  accord  with  the 
data of Yokoyama et ai. (12), obtained with comparative tryptic peptide mapping. 786  STRUCTURAL  CHARACTERISTICS  OF  Tla  PRODUCTS 
FIGURE  5.  2D chymotryptic peptide maps of H chains of TL (eluted from SDS-PAGE bands) 
from thymocytes and leukemias of various Tla genotypes. The upper four panels represent 
a  e  ¢  d  thymocytes of mice of strains A  (Tla),  BDP  (Tla),  BALB/cJ  (Tla)  and  B10.M  (Tla);  the 
lower two panels represent the A  strain leukemia ASL1  (Tla a) and the B6  leukemia  ERLD 
(Tlab). The Tla a and Tla e maps (top panels) are broadly similar. The Tla c and Tla  d maps (middle 
panels) are broadly similar. The maps of Tla  a thymocytes (top left) and leukemia cells (bottom 
left) are not distinguishable. CHORNEY  ET  AL.  787 
Leukemia cells.  Despite  the  marked  differences  in  charge  between  TL  H 
chains of A  strain  thymocytes and of A  strain  leukemia cells, noted above, the 
peptide  maps did not differ (Fig.  5).  The  peptide  map for B6  leukemia cells, 
though generally similar to the strain  A pattern, is not the same, but in the case 
of B6, there is no tbymocyte TL for comparison because B6 mice are TL- (Tlab). 
Discussion 
The two characteristics reported here, which on present evidence distinguish 
TL from other class I products of the H-2:Qa:Tla complex are, first, the doublet 
H  chain feature shown by TL of all TL  + thymocytes regardless of Tla genotype 
but  not  by  the  two  TL  +  leukemias  studied,  and  second,  the  occurrence  of 
putative TL products of higher  molecular weight in TL  + mice of all  Tla types 
except Tla a (these higher-molecular  weight products are being studied and are 
not discussed further here). 
Since the two components of the H  chain doublet could not be distinguished 
by charge  or  by peptide  mapping,  and  since  only  a  single  internally  labeled 
cytoplasmic TL precursor has so far been identified (11), the two H  chain bands 
may differ only in glycosylation, without an effect on charge. 
Only one  H  chain  band could be found in  the  two TL  ÷ leukemias  studied. 
One  possible  interpretation  is  that  two  forms  of TL  are  expressed  singly  by 
different TL  + thymocyte subpopulations, hence the single H chain band of clonal 
leukemias, but clearly there may be other explanations. 
The  differences  in  molecular  weight  and  charge  between  TL  of A  strain 
thymocytes and A  strain  leukemia cells was not accompanied by any difference 
in  the  2D  peptide  maps,  as  similarly  observed  by  Yokoyama  et  al.  (13)  in 
comparative tryptic peptide mapping. A reason for the difference in charge may 
be found in differing degrees of glycosylation that are known to occur with other 
glycoproteins of normal as compared to transformed cells (14). In short, there is 
nothing  here  to  indicate  the action  of more  than  one  Tla  gene  in  normal  or 
transformed A strain T  cells. The 2D peptide map of the single H chain band of 
B6 ERLD leukemia cells is distinctive, but there is no B6-constitutive TL with 
which to compare it, since B6 has the  Tla  b allele,  which is null with respect to 
thymocyte phenotype. 
2D  peptide  mapping  and  2D  IEF-SDS-PAGE  categorically  distinguish  TL 
from other class I products, H-2 and Qa-2, which we have studied similarly, and 
the relatively small differences among TL of various Tla types reflects the lesser 
polymorphism of Tla as compared to H-2. 
One of the aims of this study was to look for evidence of expression of more 
than one Tla gene in thymocytes or leukemia cells, since multiplicity of Tla genes 
has been inferred from the results of gene cloning and  transfer (15). Our data 
are not decisive in that regard.  BALB/c ieukemias, which we are now studying, 
may be more favorable for answering this question, because BALB thymocytes 
(Tla c) express constitutive TL antigen, whereas BALB leukemias have additional 
TL antigens which, although normally expressed by thymocytes of other mouse 
strains (e.g. Tla~),  are not expressed by BALB thymocytes (16). 788  STRUCTURAL CHARACTERISTICS OF  Tla  PRODUCTS 
Summary 
Biochemical  study  of thymus  leukemia  antigen  (TL)  from  thymocytes of 
various  Tla  genotypes and  from  leukemia cells  revealed  features that,  given 
present evidence, are peculiar to TL among class I products of the H-2:Qa:Tta 
region of chromosome 17. 
Sodium  dodecyl sulfate-polyacrylamide gel  electrophoresis  (SDS-PAGE)  of 
TL from thymocytes of all TL  + mouse strains, precipitated by anti-TL antiserum 
or monocional antibodies, showed two closely migrating bands of equal intensity 
in the heavy (H) chain position (45-50,000  mol wt).  Comparison of these two 
bands  by  two-dimensional isoelectric  focusing (2D  IEF)-SDS-PAGE  and  2D 
chymotryptic peptide mapping showed no differences indicative of protein dis- 
similarity. Thus, the two components of the H chain doublet may differ only in 
a feature of glycosylation that does not affect charge. The two leukemias studied 
gave only a single band in the H chain position. 
On 2D peptide mapping and 2D IEF-SDS-PAGE, the patterns for TL of Tla  a 
and Tla  e thymocytes, which are closely related serologically, were broadly similar, 
but clearly different from the pattern typical of Tla  c and  Tla d thymocytes. 2D 
peptide maps of TL from Tla  a thymocytes  and Tla  a leukemia cells did not differ. 
Leukemia cells  of Tla  b origin (thymocytes TL-) gave 2D peptide and 2D IEF- 
SDS-PAGE patterns of a third type. 
With the exception of Tla  a,  thymocytes of TL  + mice yielded additional TL 
products of higher molecular weight than the TL H chain. 
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